Načítá se...
The therapeutic monoclonal antibody market
Since the commercialization of the first therapeutic monoclonal antibody product in 1986, this class of biopharmaceutical products has grown significantly so that, as of November 10, 2014, forty-seven monoclonal antibody products have been approved in the US or Europe for the treatment of a variety...
Uloženo v:
| Vydáno v: | MAbs |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622599/ https://ncbi.nlm.nih.gov/pubmed/25529996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/19420862.2015.989042 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|